rewindtherapeutics.com Revenue and Competitors
Estimated Revenue & Valuation
- rewindtherapeutics.com's estimated annual revenue is currently $4M per year.
- rewindtherapeutics.com's estimated revenue per employee is $155,000
Employee Data
- rewindtherapeutics.com has 26 Employees.
- rewindtherapeutics.com grew their employee count by 8% last year.
rewindtherapeutics.com's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Head Research and Discovery | Reveal Email/Phone |
3 | Head Medicinal Chemistry | Reveal Email/Phone |
4 | Research Operations Project Manager | Reveal Email/Phone |
5 | In vivo research scientist | Reveal Email/Phone |
rewindtherapeutics.com Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is rewindtherapeutics.com?
Rewind Therapeutics is a privately held Belgian biotech company that recently completed a €15.2 million Series A financing to develop novel re-myelinating therapies for patients suffering from multiple sclerosis and other myelin-related diseases. The round was led by experienced life science investors Boehringer Ingelheim Venture Fund (BIVF), M Ventures BV (MV) and Participatiemaatschappij Vlaanderen (PMV), together with KU Leuven's Centre for Drug Design and Discovery (CD3) and KU Leuven Gemma Frisius Fonds (GFF). The company currently focuses on bringing its first proprietary small molecule product to the clinic and to further expand its pipeline of novel drug candidates targeting myelin disorders. Rewind Therapeutics is founded by CD3 (Leuven, Belgium) and Axxam S.p.A. (Milano, Italy). In close collaboration with both organizations and a world-class academic network, Rewind Therapeutics aspires to advance innovative first-in-class therapies for myelin-related diseases into fast track clinical application.
keywords:N/A
N/A
Total Funding
26
Number of Employees
$4M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Heverlee
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.5M | 31 | 7% | N/A |
#2 | N/A | 33 | 50% | N/A |
#3 | $3.9M | 34 | 62% | N/A |
#4 | $4.5M | 40 | 14% | N/A |
#5 | $6.2M | 40 | 82% | N/A |